Login

Stephen Streater: CEO of Forbidden Technologies | Stephen Streater , CEO at Forbidden Technologies plc 00:10:00

Share On Facebook Share On Twitter

The CEO of Forbidden Technologies plc is Stephen Streater.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
The limitations of human heart transplant availability - Stéphane Piat, CEO of Carmat
00:10:00
BVZ Holding CEO Fernando Lehner on H1 2022, Future Projects, and Motivating His Team Amidst Challenges | Fernando Lehner - CEO of bvz holding ag
00:10:00
Navigating Economic Turbulence: Reflections and Strategies for Investor Resilience - Patti Brennan | President and CEO, Key Financial, Inc.
00:10:00
Stage startups that uses tech to disrupt existing markets|Leslie Crowe,Partner,Bain Capital Ventures
00:10:00
Azure Minerals' Andover Lithium Project: A Transformative Year with Major Discoveries and Takeover Offer
00:10:00
Peter Bkey: Gold Royalty's Growth and Market Outlook
00:10:00
Sam Garrett Outlines Key Benefits of Artemisia Acquisition, Paving the Way for New Drilling Targets | Sam Garrett, CEO, Great Southern Copper PLC.
00:10:00
Black Mountain Energy CEO Rhett Bennett on Sale of Half Moon Prospect and Future Exploration in WA | Rhett Bennett, CEO, Black Mountain Energy Ltd.
00:10:00
In Conversation With Mr Nick Collins, Chief Operating Officer, Clarkson Dubai | Andi Case, CEO, Clarkson PLCCKN:LSE
00:10:00
Learning Technologies Group's Jonathan Satchell and Tharisa PLC CEO discuss the company's solid Q2 performance and innovative energy storage solution.
00:10:00
Graphite Discovery: From Exploration to Bankable Feasibility in North America
00:10:00
George W. Bush Reflects on Life After the Presidency and His Presidential Center

© 2017 - Neuhu+